LY 354740 is a highly selective and potent mGluR-2/3 (group II mGlu receptor) agonist. LY 354740 has been shown to be a conformationally constrained analog of glutamate with the ability to decrease forskolin-stimulated cAMP formation by more than 90%. Recent studies have found that activation of presynaptic metabotropic mGluR-2/3 induces long lasting inhibition of P/Q-type Ca2+ channels and the cAMP/protein kinase A pathway.
1. Schaffhauser, H., et al. 1997. Eur. J. Pharmacol. 334h: 289-297. PMID: 9369360 2. Schoepp, D.D., et al. 1997. Neuropharmacology. 36: 1-11. PMID: 9144636 2. Helton, D.R., et al. 1998. J. Pharmacol. Exp. Ther. 284: 651-660. PMID: 9454811 3. Klodzinska, A., et al. 1999. Neuropharmacology. 38: 1831-1839. PMID: 10608278
bvseo-msg: The resource to the URL or file is currently unavailable.;
Rated 5 out of
OrlandoOrlando, R. et al. (PubMed 25063582) reported that levels of the Rab GDP dissociation inhibitor (GDI) are altered in the prenatal restrain stress mouse model of schizophrenia and are differentially regulated by the mGlu2/3 receptor agonists, LY 379268 and LY 354740. -SCBT Publication Review
To place an order using RMB or to ship to mainland China, please visit www.scbio.cn